EPAG 10 MG COM REV CT BL AL PLAS PVC TRANS X 30
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1052501370021 -
GGREM
532726080076607 -
Código de barras
8903855098531
O que a fonte publica
- Detentor do registro
- TORRENT DO BRASIL LTDA
- Princípios ativos
- EMPAGLIFLOZINA
- Embalagem
- 10 MG COM REV CT BL AL PLAS PVC TRANS X 30
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Similar
- Classe terapêutica
- A10P1 - ANTIDIABÉTICOS INIBIDORES DE SGLT2, PUROS
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "EPAG 10 MG COM REV CT BL AL PLAS PVC TRANS X 30",
"holder": "TORRENT DO BRASIL LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"8903855098531"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "532726080076607",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "33.078.528/0001-32",
"priceRegime": "Regulado",
"productName": "EPAG",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "10 MG COM REV CT BL AL PLAS PVC TRANS X 30",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "198.60",
"icms-12": "225.68",
"icms-17": "239.28",
"icms-18": "242.20",
"icms-19": "245.19",
"icms-20": "248.25",
"icms-21": "251.39",
"icms-22": "254.62",
"icms-23": "257.92",
"icms-17.5": "240.73",
"icms-19.5": "246.71",
"icms-20.5": "249.81",
"icms-22.5": "256.26",
"icms-12-alc": "201.50",
"icms-17-alc": "213.64",
"icms-18-alc": "216.25",
"icms-19-alc": "218.92",
"icms-20-alc": "221.65",
"icms-21-alc": "224.46",
"icms-22-alc": "227.34",
"icms-23-alc": "230.29",
"withoutTaxes": "177.32",
"icms-17.5-alc": "214.94",
"icms-19.5-alc": "220.28",
"icms-20.5-alc": "223.05",
"icms-22.5-alc": "228.80"
},
"pisCofinsList": "Negativa",
"substanceText": "EMPAGLIFLOZINA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "266.41",
"icms-12": "302.74",
"icms-17": "320.99",
"icms-18": "324.90",
"icms-19": "328.91",
"icms-20": "333.02",
"icms-21": "337.23",
"icms-22": "341.56",
"icms-23": "345.99",
"icms-17.5": "322.93",
"icms-19.5": "330.95",
"icms-20.5": "335.11",
"icms-22.5": "343.76",
"icms-12-alc": "278.56",
"icms-17-alc": "295.34",
"icms-18-alc": "298.95",
"icms-19-alc": "302.64",
"icms-20-alc": "306.42",
"icms-21-alc": "310.30",
"icms-22-alc": "314.28",
"icms-23-alc": "318.36",
"withoutTaxes": "245.14",
"icms-17.5-alc": "297.14",
"icms-19.5-alc": "304.52",
"icms-20.5-alc": "308.35",
"icms-22.5-alc": "316.30"
},
"invalidBarcodes": [],
"activeSubstances": [
"EMPAGLIFLOZINA"
],
"therapeuticClass": "A10P1 - ANTIDIABÉTICOS INIBIDORES DE SGLT2, PUROS",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1052501370021",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "A10P1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:532726080076607"